Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease

Niklas Andreen1,2, Lars-Magnus Andersson1,2, Nicklas Sundell1,2

  • 1Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Insights

Hospitalized patients with chronic obstructive pulmonary disease (COPD) faced worse outcomes and higher 30-day mortality from COVID-19 compared to those without COPD. Cardiovascular disease significantly increased mortality risk in COPD patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • COVID-19 poses significant risks to hospitalized patients.
  • Chronic obstructive pulmonary disease (COPD) is a prevalent comorbidity that may affect COVID-19 outcomes.
  • Understanding the impact of COPD on COVID-19 severity is crucial for patient management.

Purpose of the Study:

  • To compare the clinical outcomes of COVID-19 in hospitalized patients with and without COPD.
  • To identify risk factors associated with mortality in COPD patients hospitalized with COVID-19.

Main Methods:

  • Retrospective analysis of 63 hospitalized COVID-19 patients with COPD.
  • Matching with 63 hospitalized COVID-19 patients without COPD based on age, gender, and admission month.
  • Univariate analysis to assess factors associated with 30-day mortality.

Main Results:

  • COPD patients exhibited a higher prevalence of comorbidities, particularly cardiovascular disease.
  • A trend towards increased 30-day mortality was observed in the COPD group (35% vs. 22%).
  • High Charlson comorbidity index and prior cerebrovascular disease were linked to 30-day mortality in COPD patients.

Conclusions:

  • Hospitalized COVID-19 patients with COPD experience more severe disease and higher mortality rates within 30 days.
  • Comorbidities, especially cardiovascular diseases, are significant predictors of mortality in this population.
  • Maintenance therapy with inhaled corticosteroids did not demonstrate a protective effect on mortality.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
657
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K